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CASE REPORT
Case Report: Cervical chondrocalcinosis as a complication of
 Gitelman syndrome [version 1; referees: 3 approved]
Zahra Iqbal ,  Paul Mead , John A. Sayer1,3
Renal Services, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
Renal Unit, Cumberland Infirmary, Carlisle, UK
Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
Abstract
Gitelman syndrome is an inherited tubulopathy leading to a hypokalaemic
metabolic alkalosis with hypomagnesaemia and hypocalciuria. Most cases are
due to mutations in , encoding the apical thiazide sensitiveSLC12A3
co-transporter in the distal convoluted tubule. Musculoskeletal effects of
Gitelman syndrome are common, including muscle weakness, tetany and
cramps. Chronic hypomagnesaemia can lead to chondrocalcinosis, which often
affects knees but can affect other joints. Here we present a case of Gitelman
syndrome complicated by cervical chondrocalcinosis leading to neck pain and
numbness of the fingers. Treatments directed at correcting both hypokalaemia
and hypomagnesaemia were initiated and allowed conservative non-surgical
management of the neck pain. Recognition of chondrocalcinosis is important
and treatments must be individualised to correct the underlying
hypomagnesaemia.
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Background
Gitelman syndrome (GS) is an autosomal recessive tubulopathy 
due to mutations in SLC12A3 encoding the thiazide sensitive sodium 
chloride co-transporter (NCC) in the distal convoluted tubule. The 
estimated prevalence is 1:40,0001. Biochemically the phenotype 
is similar to long-term thiazide diuretic treatment: hypokalemia, 
hypomagnesemia, a hypochloraemic metabolic alkalosis and 
reduced urinary calcium levels2. Although an inherited condi-
tion, the disease is usually diagnosed during adolescence or early 
adult life. However presentations late in life, often with chondrocal-
cinosis do occur3,4.
Case report
A 55-year-old lady was referred to the renal unit with persistently 
low serum potassium and magnesium levels following an episode 
of acute cholecystitis. Urinary electrolytes confirmed potassium 
wasting and hypocalciuria. On admission, her serum electrolytes 
were deranged: potassium 2.5 mmol/L, magnesium 0.31 mmol/L, 
corrected calcium 2.04 mmol/L, sodium 134 mmol/L and creatinine 
53 µmol/L. Additional biochemistry tests confirmed hyperreninae-
mic hyperaldosteronism (renin >14.4 pmol/ml/hr (NR 0.5–3.1) and 
aldosterone 2794 pmol/L (NR 100–800)). Random urine sodium 
was 97 mmol/l, urine potassium 33 mmol/l and urine osmolality 
467 mosm/kg. Biochemically, the diagnosis was consistent with 
GS.
She previously had no other significant medical history but had 
required NSAIDs for longstanding back, hip and neck pain. She 
was commenced on oral potassium and magnesium supplements 
(magnesium oxide 16 mmol/day) together with spironolactone 
100 mg daily as a long term treatment. Molecular genetic analysis 
confirmed GS with the identification of compound heterozygous 
mutations in SLC12A3 (p.Arg209Gln and p.Ser615Leu)5. Despite 
oral supplementation, serum magnesium levels remained low 
(0.5–0.6 mmol/L).
At 60 years of age, she had a MRI spine examination for worsening 
neck pain and the onset of numbness in her fingers. The MRI spine 
revealed widespread chondrocalcinosis in the cervical spine and 
soft tissues, with a large ossified bony bar at the level of C3 and C4 
compressing the spinal cord (Figure 1). In addition, there were mul-
tiple areas of chondrocalcinosis in the intra-vertebral discs, annulus 
fibrosus, ligamentum flavum and in the transverse ligament behind 
the odontoid process. Despite the fingertip numbness and severe 
chondrocalcinosis, physical examination demonstrated no apparent 
neurological loss, with normal, tone, power, reflexes and sensa-
tion. Neurosurgical advice was sought and a conservative approach 
was adopted. Oral magnesium supplementation was changed to 
magnaspartate and increased to 40 mmol/day in an attempt to nor-
malise serum magnesium levels and prevent progression of the 
chondrocalcinosis and improve symptoms. From 60 to 62 years 
of age the serum magnesium has been maintained at near normal 
levels (0.6–0.75 mmol/L) with improvement of musculoskeletal 
symptoms and no progression of any functional deficit in hand 
movements. Neurology follow-up continues to adopt observational 
and conservative management.
Discussion
Chondrocalcinosis is the deposition of calcium pyrophosphate 
crystals in the articular cartilages throughout the body and has been 
associated with the longstanding hypomagnesaemia secondary to 
GS6. Chondrocalcinosis may cause swelling, heat and tenderness 
over the affected joints. As well as GS, chondrocalcinosis may also 
be seen in association with hyperparathyroidism, haemochromatosis 
and hypophosphatasia.
Chondrocalcinosis is a known complication of GS and can affect 
various joints, most typically knees7. Cervical spine chondrocalci-
nosis due to GS, however, is not often reported. Calcium pyrophos-
phate dehydrate deposits in the peri-odontoid soft tissues can lead 
to a condition called ‘crowned dens syndrome’ which causes acute 
neck pain and has been associated with GS8. Treatment relies on 
magnesium replacement and symptom control with non-steroidal 
anti-inflammatory drugs. Surgery is rarely performed.
Patients with GS can experience salt craving, tetany and cramps, 
fatigue and severe lethargy, often impacting greatly on their qual-
ity of life5. The chondrocalcinosis associated with it further adds 
to the musculoskeletal disease burden. It is therefore important to 
monitor patients and try to correct the potassium and magnesium 
disturbances to prevent acute exacerbations and progression9. 
Complete normalisation of serum magnesium is often difficult due 
Figure 1. CT Cervical spine demonstrating a large ossified bony 
bar extending from the posterior surface of the C4 vertebral 
body up to the level of the upper surface of the C3 vertebral 
body. There are also multiple areas of calcification involving the 
intravertebral discs, annulus fibrosis, the ligmentum flavum and the 
transverse ligament behind the odontoid process.
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to diarrhoea associated with magnesium supplements. Various 
magnesium preparations are available, including magnesium oxide, 
magnesium glycerophosphate, magnaspartate, and magnesium 
lactate (Mag-Tab SR), which is slow release and is often better 
tolerated. Trial of various preparations and individual tailoring of 
dosing is required.
In summary we present a case of GS presenting with typical 
electrolyte disturbances (hypokalaemic metabolic alkalosis and 
hypomagnesaemia) complicated by severe chrondrocalcinosis of 
the cervical spine. Treatment directed at correcting these electro-
lyte disturbances has allowed an improvement of symptoms and 
avoidance of neurosurgery.
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